[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Erlotinib Hydrochloride Market Data Survey Report 2013-2025

May 2019 | 91 pages | ID: G0AD1B5628EEN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body
The global Erlotinib Hydrochloride market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:

Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type

Key manufacturers are included based on company profile, sales data and product specifications etc.:
  • Roche
  • Cipla
  • Mylan
  • Teva
  • OSI Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Beacon Pharmaceuticals
  • Raichem Lifesciences
  • United Biotech
  • CJ Corporation
  • Vivimed Labs
  • Boryung Pharmaceutical
  • Taj Pharmaceuticals
  • Pharmascience
  • Natco Pharma
  • Intas Pharmaceuticals
  • RPG Life Sciences
  • Pharmascience
  • Schwarz Pharma
  • Dr. Reddy’s Laboratories
  • Glenmark Pharmaceuticals
  • Chugai Pharmaceutical
  • DKSH
  • Firma Chun Cheong
  • Kremers Urban Pharmaceuticals
  • Ortat
  • Zuellig Pharma
Major applications as follows:
  • Non-small Cell Lung Cancer
  • Pancreatic Cancer
Major Type as follows:
  • 25mg
  • 100mg
  • 150mg
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.4 Scope of Type
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Roche
  3.1.1 Company Information
  3.1.2 Product & Services
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.1.4 Recent Development
3.2 Cipla
  3.2.1 Company Information
  3.2.2 Product & Services
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.2.4 Recent Development
3.3 Mylan
  3.3.1 Company Information
  3.3.2 Product & Services
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.3.4 Recent Development
3.4 Teva
  3.4.1 Company Information
  3.4.2 Product & Services
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.4.4 Recent Development
3.5 OSI Pharmaceuticals
  3.5.1 Company Information
  3.5.2 Product & Services
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.5.4 Recent Development
3.6 Glenmark Pharmaceuticals
  3.6.1 Company Information
  3.6.2 Product & Services
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.6.4 Recent Development
3.7 Beacon Pharmaceuticals
  3.7.1 Company Information
  3.7.2 Product & Services
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.7.4 Recent Development
3.8 Raichem Lifesciences
  3.8.1 Company Information
  3.8.2 Product & Services
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.8.4 Recent Development
3.9 United Biotech
  3.9.1 Company Information
  3.9.2 Product & Services
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.9.4 Recent Development
3.10 CJ Corporation
  3.10.1 Company Information
  3.10.2 Product & Services
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.10.4 Recent Development
3.11 Vivimed Labs
  3.11.1 Company Information
  3.11.2 Product & Services
  3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.11.4 Recent Development
3.12 Boryung Pharmaceutical
  3.12.1 Company Information
  3.12.2 Product & Services
  3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.12.4 Recent Development
3.13 Taj Pharmaceuticals
  3.13.1 Company Information
  3.13.2 Product & Services
  3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.13.4 Recent Development
3.14 Pharmascience
  3.14.1 Company Information
  3.14.2 Product & Services
  3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.14.4 Recent Development
3.15 Natco Pharma
  3.15.1 Company Information
  3.15.2 Product & Services
  3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.15.4 Recent Development
3.16 Intas Pharmaceuticals
  3.16.1 Company Information
  3.16.2 Product & Services
  3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.16.4 Recent Development
3.17 RPG Life Sciences
  3.17.1 Company Information
  3.17.2 Product & Services
  3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.17.4 Recent Development
3.18 Pharmascience
  3.18.1 Company Information
  3.18.2 Product & Services
  3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.18.4 Recent Development
3.19 Schwarz Pharma
  3.19.1 Company Information
  3.19.2 Product & Services
  3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.19.4 Recent Development
3.20 Dr. Reddy’s Laboratories
  3.20.1 Company Information
  3.20.2 Product & Services
  3.20.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.20.4 Recent Development
3.21 Glenmark Pharmaceuticals
  3.21.1 Company Information
  3.21.2 Product & Services
  3.21.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.21.4 Recent Development
3.22 Chugai Pharmaceutical
  3.22.1 Company Information
  3.22.2 Product & Services
  3.22.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.22.4 Recent Development
3.23 DKSH
  3.23.1 Company Information
  3.23.2 Product & Services
  3.23.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.23.4 Recent Development
3.24 Firma Chun Cheong
  3.24.1 Company Information
  3.24.2 Product & Services
  3.24.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.24.4 Recent Development
3.25 Kremers Urban Pharmaceuticals
  3.25.1 Company Information
  3.25.2 Product & Services
  3.25.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.25.4 Recent Development
3.26 Ortat
  3.26.1 Company Information
  3.26.2 Product & Services
  3.26.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.27 Zuellig Pharma
  3.27.1 Company Information
  3.27.2 Product & Services
  3.27.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Non-small Cell Lung Cancer
  4.1.1 Overview
  4.1.2 Non-small Cell Lung Cancer Market Size and Forecast
4.2 Pancreatic Cancer
  4.2.1 Overview
  4.2.2 Pancreatic Cancer Market Size and Forecast

5 MARKET BY TYPE BY 25MG

5.1 25mg
  5.1.1 Overview
  5.1.2 25mg Market Size and Forecast
5.2 100mg
  5.2.1 Overview
  5.2.2 100mg Market Size and Forecast
5.3 150mg
  5.3.1 Overview
  5.3.2 150mg Market Size and Forecast

6 PRICE OVERVIEW

6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type

7 CONCLUSION

LIST OF TABLES

Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Roche
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Cipla
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mylan
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of OSI Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Glenmark Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Beacon Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Raichem Lifesciences
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of United Biotech
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of CJ Corporation
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Vivimed Labs
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Boryung Pharmaceutical
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Taj Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Pharmascience
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Natco Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Intas Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of RPG Life Sciences
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Pharmascience
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Schwarz Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Dr. Reddy’s Laboratories
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Glenmark Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Chugai Pharmaceutical
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of DKSH
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Firma Chun Cheong
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Kremers Urban Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Ortat
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Zuellig Pharma

LIST OF FIGURES

Fig Global Erlotinib Hydrochloride Market Size and CAGR 2013-2018 (Million USD)
Fig Global Erlotinib Hydrochloride Market Size and CAGR 2013-2018 (Volume)
Fig Global Erlotinib Hydrochloride Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Erlotinib Hydrochloride Market Forecast and CAGR 2019-2025 (Volume)
Fig Non-small Cell Lung Cancer Market Size and CAGR 2013-2018 (Million USD)
Fig Non-small Cell Lung Cancer Market Size and CAGR 2013-2018 (Volume)
Fig Non-small Cell Lung Cancer Market Forecast and CAGR 2019-2025 (Million USD)
Fig Non-small Cell Lung Cancer Market Forecast and CAGR 2019-2025 (Volume)
Fig Pancreatic Cancer Market Size and CAGR 2013-2018 (Million USD)
Fig Pancreatic Cancer Market Size and CAGR 2013-2018 (Volume)
Fig Pancreatic Cancer Market Forecast and CAGR 2019-2025 (Million USD)
Fig Pancreatic Cancer Market Forecast and CAGR 2019-2025 (Volume)
Fig 25mg Market Size and CAGR 2013-2018 (Million USD)
Fig 25mg Market Size and CAGR 2013-2018 (Volume)
Fig 25mg Market Forecast and CAGR 2019-2025 (Million USD)
Fig 25mg Market Forecast and CAGR 2019-2025 (Volume)
Fig 100mg Market Size and CAGR 2013-2018 (Million USD)
Fig 100mg Market Size and CAGR 2013-2018 (Volume)
Fig 100mg Market Forecast and CAGR 2019-2025 (Million USD)
Fig 100mg Market Forecast and CAGR 2019-2025 (Volume)
Fig 150mg Market Size and CAGR 2013-2018 (Million USD)
Fig 150mg Market Size and CAGR 2013-2018 (Volume)
Fig 150mg Market Forecast and CAGR 2019-2025 (Million USD)
Fig 150mg Market Forecast and CAGR 2019-2025 (Volume)


More Publications